Catherine Popadiuk is a Rheumatology/Immunology physician. OpenAlex indexes 41 publications with 679 citations (h-index 11).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
2875 Broadway Fl 2
New York, NY 100257846
Telephone
212-523-1600Provider last certified this registry record 31 Oct 2024.
Industry payments
6 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Novartis Pharmaceuticals CorporationProgram year20251 payment
- Novartis Pharmaceuticals CorporationProgram year20244 payments
- GENZYME CORPORATIONProgram year20242 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Respiratory
95.4%Corticosteroid44.1%Fluticasone Propionate68%Trelegy Ellipta9%Mometasone Furoate9%Breo Ellipta7%Arnuity Ellipta7%Part D<11 patientsHistamine-1 Receptor Antagonist34.6%Azelastine Hcl73%Levocetirizine Dihydrochloride27%Part D≥32 patients+ 3 more classes in this area
Metabolism & gastrointestinal
4.6%H2 blocker4.6%Famotidine100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Proton pump inhibitors and the risk of acquiring a penicillin allergy label
Internal Medicine Journal
2023 - Guideline No. 423: Female Genital Cosmetic Surgery and Procedures
Journal of Obstetrics and Gynaecology Canada
2022 - Cost assessment of allergy procedures to improve high-value care implementation
Allergy and Asthma Proceedings
2022 - Food Allergy2022
Similar KOLs
Other experts from the same institution or the same specialty.
David J. Hunter
The University of Sydney
Aziz Sheikh
Universiti Malaysia Terengganu
Nima Hafezi‐Nejad
The University of Sydney
Gelin Xu
Second Affiliated Hospital of Nanjing Medical University
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”